Evidence map›Paper›PMID 26558438›Full record

ArticleScientific reports2015

Quercitrin for periodontal regeneration: effects on human gingival fibroblasts and mesenchymal stem cells.

Manuel Gómez-Florit, Marta Monjo, Joana M Ramis

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05928546 (Efficacy of Quercetin Nanoemulgel as Adjunct Local Delivery Drug in Non-surgical Treatment of Periodontitis), which is not on this map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05928546 phase1unknown statusnot on this mapstarted 2024, after this paper: background citation

Efficacy of Quercetin Nanoemulgel as Adjunct Local Delivery Drug in Non-surgical Treatment of Periodontitis

TypeinterventionalSponsorAssiut UniversityRan2024 to 2024Enrolled20ConditionsInflammation GumArmsQuercetin, scaling and root planing
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Review
  3. OptimizedAntioxidants (Basel, Switzerland) · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Manuel Gómez-FloritGroup of Cell Therapy and Tissue Engineering, Research Institute on Health Sciences (IUNICS). University of Balearic Islands, Palma de Mallorca, Spain.
Marta MonjoGroup of Cell Therapy and Tissue Engineering, Research Institute on Health Sciences (IUNICS). University of Balearic Islands, Palma de Mallorca, Spain.
Joana M RamisGroup of Cell Therapy and Tissue Engineering, Research Institute on Health Sciences (IUNICS). University of Balearic Islands, Palma de Mallorca, Spain.
Research Institute of Health Sciences · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Periodontal disease (PD) is the result of an infection and chronic inflammation of the gingiva that may lead to its destruction and, in severe cases, alveolar bone and tooth loss. The ultimate goal of periodontal treatment is to achieve periodontal soft and hard tissues regeneration. We previously selected quercitrin, a catechol-containing flavonoid, as a potential agent for periodontal applications. In this study, we tested the ability of quercitrin to alter biomarker production involved in periodontal regeneration on primary human gingival fibroblasts (hGF) and primary human mesenchymal stem cells (hMSC) cultured under basal and inflammatory conditions. To mimic PD inflammatory status, interleukin-1 beta (IL-1β) was used. The expression of different genes related to inflammation and extracellular matrix were evaluated and prostaglandin E2 (PGE2) production was quantified in hGFs; alkaline phosphatase (ALP) activity and calcium content were analysed in hMSCs. Quercitrin decreased the release of the inflammatory mediator PGE2 and partially re-established the impaired collagen metabolism induced by IL-1β treatment in hGFs. Quercitrin also increased ALP activity and mineralization in hMSCs, thus, it increased hMSCs differentiation towards the osteoblastic lineage. These findings suggest quercitrin as a novel bioactive molecule with application to enhance both soft and hard tissue regeneration of the periodontium.

Indexed as

AdultCell DifferentiationCells, CulturedCytokinesFemaleFibroblastsGene Expression RegulationGingivaHumansInflammation MediatorsInterleukin-1betaMaleMesenchymal Stem CellsMiddle AgedOsteoblastsOsteogenesisCytokinesInflammation MediatorsInterleukin-1betaQuercetinquercitrin

Identifiers

PMID26558438
PMCPMC4642307
OpenAlexW2408787816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.